About
CAR-T Therapies
Areas of Focus
Categories
Stem Cell & Cellular TherapyAustralia
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
177
By Phase
PHASE1/PHASE2: 1PHASE1: 1PHASE2/PHASE3: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
Today
Hover over trial bars to see details
Recent Trials
NCT06055439Lead Sponsor
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
PHASE1/PHASE2Recruiting
135 participants
Started: May 15, 2024 · Completed: May 31, 2027
NCT05627323Lead Sponsor
CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma
PHASE1Active, not recruiting
42 participants
Started: Jun 6, 2023 · Completed: Jan 31, 2041
NCT00004255Lead Sponsor
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
PHASE2/PHASE3Completed
Started: Mar 31, 2000 · Completed: May 31, 2003
Locations (1)
Headquarters
Carlton, Australia
Map
Loading map...